Novel reporter probes for HSV1-tk Gene expression

Molecular Imaging in Oncology

Volumn , Issue , 2008, Pages 405-428

  Alauddin, Mian M ^a   Gelovani, Juri G ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957981246     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (87)

1. Moolten FL, Wells JM, Heyman RA, et al. Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene. Hum Gene Therapy 1990; 1:125-134.
2. Culver KW, Ram Zvi, Wallbridge S, et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 1992; 256:1550-1552.
3. Oldfield EH, Ram Zvi, Culver K, et al. Clinical protocols: gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Human Gene Therapy 1993; 4:39-69.
4. Ram Zvi, Culver KW, Oshiro EM, et al. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector producing cells. Nat Med 1997; 3:1354-1361.
5. Tjuvajev JG, Avril N, Oku T, et al. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res 1998; 58:4333-1341.
6. Gambhir SS, Barrio JR, Phelps ME, et al. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci, USA 1999; 2333-2338.
7. Urbain JC. Reporter genes and imagene. J Nucl Med 2001; 42:106-109.
8. Tjuvajev JG, Stockhammer G, Desai R, et al. Imaging the expression of transfected genes in vivo. Cancer Res 1995; 55:6126-6132.
9. Gambhir SS, Barrio JR, Herschman HR, et al. Assays for non-invasive imaging of reporter gene expression. Nucl Med Biol 1999; 26:481-490.
10. Tjuvajev JG, Chen SH, Joshi A, et al. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo. Cancer Res 1999; 59:5186-5193.
11. 18F]-FHBG) as a probe for PET imaging of gene expression in tumor-bearing nude mice. Anticancer Res 1998; 18:4992-4993.
12. 18F]-FHBG): a new potential imaging agent for viral infection and gene therapy using PET. Nucl Med Biol 1998; 25:175-180.
13. 18F]-FHPG) in vitro and in vivo as a probe for PET imaging of gene incorporation and expression in tumors. Nucl Med Biol 1999; 26:371-376.
14. Yu Y, Annala AJ, Barrio JR, et al. Quantification of gene expression by imaging reporter gene expression in living animals. Nat Med 2000; 6:933-937.
15. 18F]-FHBG for in vivo measurement of suicide gene expression with PET. J Nucl Med 2001; 42:1682-1690.
16. 18F]-fluoropenci-clovir: an improved reporter probe for imaging HSV1-tk reporter gene expression in vivo using PET. J Nucl Med 2001; 42:96-105.
17. Jacobs A, Tjuvajev JG, Dubrovin M, et al. Positron emission tomography-based imaging of transgene expression mediated by replication conditional, oncolytic herpes simplex virus type-1 mutant vectors of cancer. Cancer Res 2001; 61:2983-2995.
18. Haberkorn U, Khazaie K, Morr I, et al. Ganciclovir uptake in human mammary carcinoma cells expressing herpes simplex virus thymidine kinase. Nucl Med Biol 1998; 25:367-373.
19. Tjuvajev JG, Joshi A, Callegari J, et al. A general approach to the non-invasive imaging of transgene using cis-linked herpes virus thymidine kinase. Neoplasia 1999; 1:315-320.
20. 18F]FHPG): a potential imaging agent of viral infection and gene therapy using PET. Nucl Med Biol 1996; 23:787-792.
21. 18F]fluoro-1-hydroxy-2-propoxy)methyl]guanine. J Labelled Compd Radiopharm 1995; 37:193-195.
22. 18F]fluoro-1-hydroxy-2-propoxy) methyl]guanine as radiopharmaceuticals for gene therapy. J Labelled Compd Radiopharm 1999; 42:S627-S629.
23. 18F]-fluoroguanine derivatives: in vivo probes for imaging gene expression with PET. Nucl Med Biol 2000; 27:157-162.
24. Tjuvajev JG, Doubrovin M, Akhurst T, et al. Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. J Nucl Med 2002; 43:1072-1083.
25. Watanabe KA, Reichman W, Hirota K, et al. Nucleosides 110. Synthesis and herpes virus activity of some 2'-fluoro-2'-deoxyarabinofuranosyl pyrimidine nucleosides. J Med Chem 1979; 22:21-24.
26. Perlman ME, Watanabe KA, Schinazi RF, et al. Nucleoside 133. Synthesis of 5-alkenyl-1-(2-deoxy-2-fluoro-B-d-arabi-nofuranosyl)cytocines and related pyrimidine nucleosides as potential antiviral agents. J Med Chem 1985; 28:741-748.
27. Tann CH, Brodfuehrer PR, Brundidge SP, et al. Fluoro-carbohydrates in synthesis. An efficient synthesis of 1-(2-deoxy-2-fluoro-B -d-arabinofuranosyl)-5-iodouracil (B-FIAU) and 1-(2-deoxy-2-fluoro-B-d-arabinofuranosyl) 5-methyluracil (B-FIAU). J Org Chem 1985; 50: 3644-3647.
28. Watanabe KA, Su T-L, Reichman U, et al. Nucleosides. 129. Synthesis of antiviral nucleosides: 5-alkenyl-1-(2-deoxy-2-fluoro-B-d-arabinofuranosy)uracis. J Med Chem 1984; 27:91-94.
29. 11C]-FMAU): a potential nucleoside analogue for in vivo study of cellular proliferation with PET. Nucl Med Biol 1995; 22:783-789.
30. 18F]-FMAU). J Labelled Compd Radiopharm 2002; 45:583-590.
31. 18F]fluoro-5-methyl-1-B-d-arabinofurano-syluracil and its 5-substituted nucleosides). J Labelled Compd Radiopharm 2003; 46:285-289.
32. 18F]FIAU, as potential PET agents for imaging cellular proliferation. Nucl Med Biol 2003; 30:215-224.
33. 18F] labeled pyrimidine nucleosides for positron emission tomography imaging of herpes simplex virus 1 thymidine kinase gene expression. J Med Chem 2006; 49(17):5377-5381.
34. Reichman U, Watanabe KA, Fox JJ. A practical synthesis of 2-deoxy-fluoro-d-arabinofuranose derivatives. Carbohydrate Res 1975; 42:233-240.
35. ' substituted arabino nucleosides. J Med Chem 1987; 30:2314-2316.
36. 18F]-l-FMAU) for PET. Appl Radiat Isot 2007; 65(8):941-946.
37. 18F]fluoroarabinofura-nosyluracil (D-FMAU and L-FMAU) in HSV1-tk gene expression cell line bearing mice. Joint Molecular Imaging Conference, Providence, Rhode Island, Sept 8-11, 2007.
38. Yu C-H, Eisenbarth J, Runz A, et al. Synthesis of 5-(2-radiohaloethyl)- and 5-(2-radiohalovinyl)-2'-deoxyuridines. Novel types of radiotracer for monitoring cancer gene therapy with PET. J Labelled Compd Radiopharm 2003; 46:421-439.
39. 18F] fluoroethyl-1-B-d-arabinofuranosyluracil. Nucl Med Biol 2005; 32(8):811-819.
40. 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer. J Nucl Med 2006; 47:1161-1171.
41. 18F-radiolabeling and biological evaluation of C-6 alky-lated pyrimidine nucleoside analogues. Nucleosides Nucleotides Nucleic acids 2004; 23:1707-1721.
42. 18F-labeled acyclic purine and pyrimidine nucleosides intended for monitoring gene expression. Radiochimica Acta 2005; 93 (9-10):585-588.
43. Grote M, Noll B, Noll S. Syntheses of novel modified acyclic purine and pyrimidine nucleosides as potential substrates of herpes simplex virus type-1 thymidine kinase for monitoring gene expression. Can J Chem 2004; 82 (4):513-523.
44. Elion GB, Furman PA, Fyfe JA, et al. Selectivity of action of an antiherpetic agent, 9-(2-hydroxy-ethoxymathyl)gua-nine. Proc Natl Acad Sci U S A 1977; 74:5716-5720.
45. Cheng Y-C, Grill SP, Dutschman GE, et al. Metabolism of 9-(1, 3-dihydroxy-2-propoxymethyl)guanine, a new antiherpes virus compound in herpes simplex virus-infected cells. J Biol Chem 1983; 258:12460-12464.
46. Boyd MR, Bacon TH, Sutton D, et al. Antiherpes virus activity of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) in cell culture. Antimicrob Agents Chemo-ther 1987; 31:1238-1242.
47. Martin JC, McGee D, Jeffrey G, et al. Synthesis and antiherpes-virus activity of acyclic 2'-deoxyguanosine analogues related to 9-[(1, 3-dihydroxy-2-propoxy)methyl]-guanine. J Med Chem 1986; 29:1384-1389.
48. 18F]FHBG) for gene therapy. Nucl Med Biol 2001; 28(7):875-883.
49. 18F] FHBG employing dual Sep-Pak SPE techniques. Bioorg Med Chem Lett 2003; 13:3933-3938.
50. 18F]fluoro-3-hydrox-ymethylbutyl) guanine for gene therapy studies. Mol Imaging Biol 2002; 4:415-424.
51. 18F] FHBG. Nucl Med Biol 2004; 31:133-138.
52. 18F]-FHPG) for gene expression imaging. Appl Radiat Isot 2007; 65:57-63.
53. 18FFPCV] as a novel PET probe for imaging HSV1-tk reporter gene expression. Nucl Med Biol 2007; 34:717-725.
54. Schipper ML, Goris ML, Gambhir SS. Evaluation of herpes simplex virus 1 thymidine kinase-mediated trapping of (131)I FIAU and prodrug activation of ganciclovir as a synergistic cancer radio/chemotherapy. Mol Imaging Biol 2007; 9(3):110-116.
55. Dempsey MF, Wyper D, Owens J, et al. Assessment of 123I-FIAU imaging of herpes simplex viral gene expression in the treatment of glioma. Nucl Med Commun 2006; 27(8):611-617.
56. Hsieh CH, Liu RS, Wang HE, et al. In vitro evaluation of herpes simplex virus type 1 thymidine kinase reporter system in dynamic studies of transcriptional gene regulation. Nucl Med Biol 2006; 33(5):653-660.
57. Verwijnen SM, Sillevis Smith PA, Hoeben RC, et al. Molecular imaging and treatment of malignant gliomas following adenoviral transfer of the herpes simplex virus-thymidine kinase gene and the somatostatin receptor subtype 2 gene. Cancer Biother Radiopharm 2004; 19(1): 111-120.
58. Choi TH, Ahn SH, Kwon HC, et al. In vivo comparison of IVDU and IVFRU in HSV1-TK gene expressing tumor bearing rats. Appl Radiat Isot 2004; 60(1):15-21.
59. 76Br-FBAU as a PET reporter probe for HSV1-tk gene expression imaging using mouse models of human glioma. J Nucl Med 2005; 46:1923-1930.
60. Zhang Y, Lin J, Pan D. Synthesis of a technetium-99m labeled tricyclic ganciclovir analog for non-invasive reporter gene expression imaging. Bioorg Med Chem Lett 2007; 17:741-744.
61. ter Horst M, Verwijnen SM, Brouwer E, et al. Locoregional delivery of adenoviral vectors. J Nucl Med 2006; 47 (9):1483-1489.
62. Satio Y, Price RW, Rottenberg DA. Quantitative autoradiographic maping of herpes simplex virus encephalitis with radiolabeled antiviral drug. Science 1982; 217:1151-1153.
63. 18F]FHPG as PET tracers for herpes simplex virus thymidine kinase enzyme activity and human cytomegalo-virus infections. Nucl Med Biol 2000; 27:113-119.
64. Alauddin MM, Shahinaian A, Gordon EM, et al. Evaluation of 2'-deoxy-2'-fluoro-5-methyl-1-B-d-arabinofurano-syluracil as a potential gene imaging agents for HSV1-tk expression in vivo. Mol Imaging 2002; 1:74-81.
65. Alauddin MM, Shahinaian A, Gordon EM, et al. Direct comparison of radiolabeled probes FMAU, FHBG and FHPG as PET imaging agents for HSV1-tk gene expression in human breast cancer model. Mol Imaging 2004; 3: 76-84.
66. 18F]FCAU), and their biological evaluation as markers for gene expression. Nucl Med Biol 2004; 31:399-105.
67. 18F]fluoro-5-fluoro-1-B-D-arabinofuranosyluracil as a potential PET imaging agent for gene expression. J Nucl Med 2004; 45:2063-2069.
68. 18F]-FEAU) as markers for suicide gene expression. Eur J Nucl Med Mol Imaging 2007; 34:822-829.
69. Alauddin MM, Shahinian A, Conti PS. Evaluation of 2'-deoxy-2'-fluoro-5-substituted-1-B-d-arabinofuranosylura-cils as markers for suicide gene expression in breast cancer cells. J Nucl Med 2005; 46:35.
70. 18F-FEAU as a radiotracer for Herpes simplex virus thymidine kinase gene expression: in-vitro comparison with other PET tracers. Nucl Med Commun 2006; 27:25-30.
71. 3H]PCV for monitoring reporter gene expression with wild type and mutated herpes simplex virus type 1 thymidine kinase in cell culture. Mol Imaging Biol 2005; 7:296-303.
72. Tseng JC, Zanzonico PB, Levin B, et al. Tumor specific in vivo transfection with HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis for prodrug ganciclovir activation and PET. J Nucl Med 2006; 47:1136-1143.
73. Hajitou A, Trepel M, Lilley CE, et al. A hybrid vector for ligand-directed tumor targeting and molecular imaging. Cell 2006; 125:385-398.
74. 18F]-FEAU. Nat Protoc 2007; 2:416-423.
75. 18F]FLT. Eur J Nucl Med Mol Imaging 2008; 35:990-998.
76. 18F]FHPG as PET tracer for HSV1-tk gene expression. Nucl Med Biol 2003; 30:651-660.
77. 18F]FHBG: a reporter probe for imaging herpes simplex virus Type-1 thymidine kinase reporter gene expression. J Nucl Med 2001; 42:1225-1234.
78. Herschman HR, MacLaren DC, Iyer M, et al. Seeing is believing: non-invasive, quantitative and repetitive imaging of reporter gene expression in living animals, using positron emission tomography. J Neurosci Res 2000; 59:699-705.
79. Gambhir SS, Barrio JR, Herschman HR, et al. Assays for noninvasive imaging of reporter gene expression. Nucl Med Biol 1999; 26:481-490.
80. Yu Y, Annala AJ, Barrio JR, et al. Quantification of target gene expression by imaging reporter gene expression in living animals. Nat Med 2000; 6:933-937.
81. Yaghoubi SS, Wu L, Liang Q, et al. Direct correlation between positron emission tomographic images of two reporter genes delivered by two distinct adenoviral vectors. Gene Ther 2001; 8:1072-1080.
82. 18F-FHBG for quantitating herpes simplex virus type 1 thymidine kinase reporter gene expression in living animals using PET. J Nucl Med 2004; 45: 1560-1570.
83. 18F] FHBG. Nat Protocols 2006; 1:3069-3075.
84. Black ME, Newcomb TG, Wilson HM, et al. Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy. Proc Natl Acad Sci U S A 1996; 93:3525-3529.
85. Black ME, Kokoris MS, Sabo P. Herpes simplex virus-1 thymidine kinase mutants created by semi-random sequence mutagenesis improve prodrug-mediated tumor cell killing. Cancer Res 2001; 61:3022-3026.
86. Bazarini J, Liekens S, Solaroli N, et al. Engineering of a single conserved amino acid residue of herpes simplex virus type 1 thymidine kinase allows a predominant shift from pyrimidine to purine nucleoside phosphorylation. J Biol Chem 2006; 281:19273-19279.
87. Najjar A, Nishii R, Maxwell D, et al. PET imaging with a novel mutant HSV1-tk reporter gene with enhanced specificity to acycloguanosine nucleoside analogs. J Nucl Med 2007, (submitted).